7-fluoro-4-oxo-N-(1-(3-oxo-2,3,4,6,7,8-hexahydroindeno[5,6-b][1,4]oxazin-6-yl)piperidin-4-yl)-4H-chromene-2-carboxamide

ID: ALA384919

Chembl Id: CHEMBL384919

PubChem CID: 44417899

Max Phase: Preclinical

Molecular Formula: C26H24FN3O5

Molecular Weight: 477.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1COc2cc3c(cc2N1)C(N1CCC(NC(=O)c2cc(=O)c4ccc(F)cc4o2)CC1)CC3

Standard InChI:  InChI=1S/C26H24FN3O5/c27-15-2-3-17-21(31)12-24(35-22(17)10-15)26(33)28-16-5-7-30(8-6-16)20-4-1-14-9-23-19(11-18(14)20)29-25(32)13-34-23/h2-3,9-12,16,20H,1,4-8,13H2,(H,28,33)(H,29,32)

Standard InChI Key:  YNFBUKHNBHSFFK-UHFFFAOYSA-N

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCHR1 Tchem Melanin-concentrating hormone receptor 1 (5587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCHR2 Tchem Melanin-concentrating hormone receptor (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 477.49Molecular Weight (Monoisotopic): 477.1700AlogP: 3.14#Rotatable Bonds: 3
Polar Surface Area: 100.88Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.73CX Basic pKa: 7.37CX LogP: 1.93CX LogD: 1.65
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.60Np Likeness Score: -0.66

References

1. Souers AJ, Iyengar RR, Judd AS, Beno DW, Gao J, Zhao G, Brune ME, Napier JJ, Mulhern MM, Lynch JK, Freeman JC, Wodka D, Chen CJ, Falls HD, Brodjian S, Dayton BD, Diaz GJ, Bush EN, Shapiro R, Droz BA, Knourek-Segel V, Hernandez LE, Marsh KC, Reilly RM, Sham HL, Collins CA, Kym PR..  (2007)  Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylamines.,  17  (4): [PMID:17188866] [10.1016/j.bmcl.2006.11.061]

Source